Evidence map›Paper›PMID 42301915›Full record

ArticleNucleic acids research2026

Target RNA-triggered CRISPR-Cas12a2 preferentially cleaves collateral DNA over RNA.

Sobita Kunwar, Thomson Hallmark, Sudeshna Manna, Dylan Keiser, Bronson Naegle, Aaron Thomas, Chase L Beisel, Ryan N Jackson

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sobita KunwarDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT 84322, United States.
Thomson HallmarkDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT 84322, United States.
Sudeshna MannaHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg 97080, Germany.
Dylan KeiserDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT 84322, United States.
Bronson NaegleDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT 84322, United States.
Aaron ThomasCenter for Integrated Biosystems, Utah State University, Logan, UT 84322, United States.
Chase L BeiselHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg 97080, Germany.ORCID 0000-0003-0650-9943
Ryan N JacksonDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT 84322, United States.ORCID 0000-0001-7403-3794

Funding

Determining the Structure and Function of Newly Discovered Immune SystemsR35GM138080 · NIGMS · UTAH STATE UNIVERSITY · PI Ryan Neal Jackson · 2020 to 2026
$2.8M
European Research Council Proof-of-Concept award 101158249Helmholtz Center for Infection Research (HZI) Singh-Chhatwal-Postdoctoral FellowshipNIGMS NIH HHS R35GM138080NIH HHS
6 · The paper itself

Abstract

CRISPR-Cas systems often rely on collateral cleavage of nucleic-acid substrates to combat recognized mobile genetic elements. Of the CRISPR-associated (Cas) RNA-guided effector nucleases, Cas12a2 stands out as the only known example exhibiting rapid collateral cleavage of three distinct substrates: single-stranded (ss)RNA, ssDNA, and double-stranded (ds)DNA, after activating upon binding cognate RNA. However, little is known about the underlying mechanisms of collateral cleavage. Here, we show, using enzyme kinetics and inhibition assays, that Cas12a2 preferentially cleaves collateral DNA over RNA substrates, even when RNA substrates are more abundant. Additionally, using enzyme mutants, enzyme kinetics, and plasmid cleavage assays, we determine that the dsDNA cleavage mechanism relies on the 'aromatic clamp' residues that stabilize unwound and distorted dsDNA in the RuvC nuclease active site. Leveraging the cleavage preference for collateral DNA, we demonstrate that RNA-activated Cas12a2 can readily cleave a ssDNA probe in the presence of high concentrations of non-target RNA, while an RNA-targeting Cas13a cannot. This work provides foundational kinetic and biochemical insights into the collateral cleavage mechanism and substrate preferences of Cas12a2, with immediate implications for understanding Cas12a2-based immunity and developing Cas12a2-based technologies.

Indexed as

Bacterial ProteinsCRISPR-Associated ProteinsCRISPR-Cas SystemsDNADNA CleavageEndodeoxyribonucleasesRNADNA, Single-StrandedKineticsBacterial ProteinsCRISPR-Associated ProteinsDNADNA, Single-StrandedEndodeoxyribonucleasesRNA

Identifiers

PMID42301915
PMCPMC13270198

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.